Bannerman Energy Ltd (ASX:BMN)

Intra-Cellular Therapies Income Statement

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Other Revenue	-	-	-	0.1	-	-
Revenue	-	-	-	0.1	-	-
Gross Profit	-	-	-	0.1	-	-
Selling, General & Admin	6.51	5.69	4.5	3.54	2.31	2.42
Other Operating Expenses	-	-	-	0	-	0.03
Operating Expenses	6.6	5.74	6.08	3.57	2.34	2.47
Operating Income	-6.6	-5.74	-6.08	-3.47	-2.34	-2.47
Interest Expense	-0.04	-0.03	-0.01	-0.01	-0	-0.01
Interest & Investment Income	3.01	1.62	1.39	-	0.03	0.1
Earnings From Equity Investments	-0.21	-1.01	-0.05	-	-	-
EBT Excluding Unusual Items	-3.8	-5.16	-4.75	-3.48	-2.31	-2.38
Gain (Loss) on Sale of Investments	-2.29	-4.4	-	-	-	-
Gain (Loss) on Sale of Assets	0.01	-0	-	-	-	-
Other Unusual Items	-	-	-	-	0.04	0.06
Pretax Income	-6.09	-9.56	-4.75	-3.48	-2.28	-2.32
Earnings From Continuing Operations	-6.09	-9.56	-4.75	-3.48	-2.28	-2.32
Minority Interest in Earnings	-0.12	0.05	0.11	0.03	0.02	0.04
Net Income	-6.21	-9.52	-4.64	-3.45	-2.25	-2.27
Net Income to Common	-6.21	-9.52	-4.64	-3.45	-2.25	-2.27
Shares Outstanding (Basic)	157	152	150	128	111	105
Shares Outstanding (Diluted)	157	152	150	128	111	105
Shares Change (YoY)	4.28%	1.15%	17.27%	15.30%	5.48%	1.42%
EPS (Basic)	-0.04	-0.06	-0.03	-0.03	-0.02	-0.02
EPS (Diluted)	-0.04	-0.06	-0.03	-0.03	-0.02	-0.02
Free Cash Flow	-34.26	-18.19	-9.28	-7.42	-2.92	-2.12
Free Cash Flow Per Share	-0.22	-0.12	-0.06	-0.06	-0.03	-0.02
Gross Margin	-	-	-	100.00%	-	-
Operating Margin	-	-	-	-3508.08%	-	-
Profit Margin	-	-	-	-3485.86%	-	-
Free Cash Flow Margin	-	-	-	-7494.95%	-	-
EBITDA	-6.6	-5.73	-4.53	-3.47	-2.34	-2.46
D&A For EBITDA	0	0.01	1.55	0	0	0.01
EBIT	-6.6	-5.74	-6.08	-3.47	-2.34	-2.47

Source: S&P Global Market Intelligence. Standard template. Financial Sources.